* Key recommended reading is highlighted with an asterisk
Abramson J, Wright EM. (2009) Structure and function of Na(+)-symporters with inverted repeats.
Curr. Opin. Struct. Biol., 19 (4): 425-32.
[PMID:19631523]
Amenta F, Tayebati SK. (2008) Pathways of acetylcholine synthesis, transport and release as targets for treatment of adult-onset cognitive dysfunction.
Curr. Med. Chem., 15 (5): 488-98.
[PMID:18289004]
*
Bailey CJ. (2011) Renal glucose reabsorption inhibitors to treat diabetes.
Trends Pharmacol. Sci., 32 (2): 63-71.
[PMID:21211857]
Bazalakova MH, Blakely RD. (2006) The high-affinity choline transporter: a critical protein for sustaining cholinergic signaling as revealed in studies of genetically altered mice.
Handb Exp Pharmacol, (175): 525-44.
[PMID:16722248]
Bizhanova A, Kopp P. (2009) Minireview: The sodium-iodide symporter NIS and pendrin in iodide homeostasis of the thyroid.
Endocrinology, 150 (3): 1084-90.
[PMID:19196800]
Bołdys A, Okopień B. (2009) Inhibitors of type 2 sodium glucose co-transporters--a new strategy for diabetes treatment.
Pharmacol Rep, 61 (5): 778-84.
[PMID:19904000]
*
Chao EC, Henry RR. (2010) SGLT2 inhibition--a novel strategy for diabetes treatment.
Nat Rev Drug Discov, 9 (7): 551-9.
[PMID:20508640]
*
Darrouzet E, Lindenthal S, Marcellin D, Pellequer JL, Pourcher T. (2014) The sodium/iodide symporter: state of the art of its molecular characterization.
Biochim. Biophys. Acta, 1838 (1 Pt B): 244-53.
[PMID:23988430]
Ferguson SM, Blakely RD. (2004) The choline transporter resurfaces: new roles for synaptic vesicles?.
Mol. Interv., 4 (1): 22-37.
[PMID:14993474]
Ganapathy V, Thangaraju M, Gopal E, Martin PM, Itagaki S, Miyauchi S, Prasad PD. (2008) Sodium-coupled monocarboxylate transporters in normal tissues and in cancer.
AAPS J, 10 (1): 193-9.
[PMID:18446519]
Ganapathy V, Thangaraju M, Prasad PD. (2009) Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond.
Pharmacol. Ther., 121 (1): 29-40.
[PMID:18992769]
Ghosh RK, Ghosh SM, Chawla S, Jasdanwala SA. (2011) SGLT2 Inhibitors: A New Emerging Therapeutic Class in the Treatment of Type 2 Diabetes Mellitus.
J Clin Pharmacol, [Epub ahead of print].
[PMID:21543663]
*
Haga T. (2014) Molecular properties of the high-affinity choline transporter CHT1.
J. Biochem., 156 (4): 181-94.
[PMID:25073461]
*
Kinne RK, Castaneda F. (2011) SGLT inhibitors as new therapeutic tools in the treatment of diabetes.
Handb Exp Pharmacol, (203): 105-26.
[PMID:21484569]
Okuda T, Haga T. (2003) High-affinity choline transporter.
Neurochem. Res., 28 (3-4): 483-8.
[PMID:12675135]
Ribeiro FM, Black SA, Prado VF, Rylett RJ, Ferguson SS, Prado MA. (2006) The "ins" and "outs" of the high-affinity choline transporter CHT1.
J. Neurochem., 97 (1): 1-12.
[PMID:16524384]
Sabino-Silva R, Mori RC, David-Silva A, Okamoto MM, Freitas HS, Machado UF. (2010) The Na(+)/glucose cotransporters: from genes to therapy.
Braz. J. Med. Biol. Res., 43 (11): 1019-26.
[PMID:21049241]
Said HM. (2009) Cell and molecular aspects of human intestinal biotin absorption.
J. Nutr., 139 (1): 158-62.
[PMID:19056639]
Sarter M, Parikh V. (2005) Choline transporters, cholinergic transmission and cognition.
Nat. Rev. Neurosci., 6 (1): 48-56.
[PMID:15611726]
Uldry M, Thorens B. (2004) The SLC2 family of facilitated hexose and polyol transporters.
Pflugers Arch., 447 (5): 480-9.
[PMID:12750891]
*
Whalen K, Miller S, Onge ES. (2015) The Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Treatment of Type 2 Diabetes.
Clin Ther, 37 (6): 1150-66.
[PMID:25891804]
*
Wilding JP. (2014) The role of the kidneys in glucose homeostasis in type 2 diabetes: clinical implications and therapeutic significance through sodium glucose co-transporter 2 inhibitors.
Metab. Clin. Exp., 63 (10): 1228-37.
[PMID:25104103]
*
Wright EM. (2013) Glucose transport families SLC5 and SLC50.
Mol. Aspects Med., 34 (2-3): 183-96.
[PMID:23506865]
*
Wright EM, Loo DD, Hirayama BA. (2011) Biology of human sodium glucose transporters.
Physiol. Rev., 91 (2): 733-94.
[PMID:21527736]
Wright EM, Loo DD, Hirayama BA, Turk E. (2004) Surprising versatility of Na+-glucose cotransporters: SLC5.
Physiology (Bethesda), 19: 370-6.
[PMID:15546855]
Wright EM, Turk E. (2004) The sodium/glucose cotransport family SLC5.
Pflugers Arch., 447 (5): 510-8.
[PMID:12748858]